| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -1.17M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, JSPR returned -76.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -62.7% |
| 1 year | -76.7% |
| 5 years | -99.3% |
| All-time high | $102.60 (Sep 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in JSPR would be worth today ›No. Jasper Therapeutics, Inc. has not paid a dividend in the past 12 months.
Jasper Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol JSPR.
Jasper Therapeutics, Inc. is part of the Healthcare sector.
Jasper Therapeutics, Inc. has a market cap of 22.70M USD, based on the latest quote.
Jasper Therapeutics, Inc. is expected to report earnings around Nov 10, 2026. That date is an estimate and has not been confirmed by the company.
